Australia's healthtech sector is exhibiting structural, not cyclical, growth in 2026. The digital health market, valued at USD $8.9 Billion in 2025, is forecast to reach USD $31.1 Billion by 2034 at a CAGR of 14.92%, underpinned by AI-led diagnostics, remote patient monitoring, aged care digitisation and a Federal Government committing billions to national digital health infrastructure.

The global landscape of sleep medicine is currently witnessing a paradigm shift, transitioning from a focus on primary respiratory disorders toward a comprehensive management model of neurological and sleep-disordered breathing conditions. Central to this evolution is the strategic acquisition of Noctrix Health, Inc. by ResMed (NYSE: RMD), a transaction valued at approximately $340 Million. This acquisition, announced during ResMed’s third-quarter fiscal year 2026 earnings ca